- Home
- SCSC vs SPRY Comparison
SCSC vs SPRY Comparison
Compare SCSC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCSC
- SPRY
- Stock Information
- Founded
- SCSC 1992
- SPRY 2015
- Country
- SCSC United States
- SPRY United States
- Employees
- SCSC N/A
- SPRY N/A
- Industry
- SCSC Retail: Computer Software & Peripheral Equipment
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- SCSC Technology
- SPRY Health Care
- Exchange
- SCSC Nasdaq
- SPRY Nasdaq
- Market Cap
- SCSC 1.1B
- SPRY 1.1B
- IPO Year
- SCSC 1994
- SPRY N/A
- Fundamental
- Price
- SCSC $50.46
- SPRY $12.57
- Analyst Decision
- SCSC Hold
- SPRY Strong Buy
- Analyst Count
- SCSC 1
- SPRY 4
- Target Price
- SCSC N/A
- SPRY $26.00
- AVG Volume (30 Days)
- SCSC 260.4K
- SPRY 1.5M
- Earning Date
- SCSC 02-04-2025
- SPRY 11-13-2024
- Dividend Yield
- SCSC N/A
- SPRY N/A
- EPS Growth
- SCSC N/A
- SPRY N/A
- EPS
- SCSC 3.14
- SPRY N/A
- Revenue
- SCSC $3,159,084,000.00
- SPRY $2,568,000.00
- Revenue This Year
- SCSC $2.58
- SPRY $66,750.00
- Revenue Next Year
- SCSC $4.90
- SPRY $508.63
- P/E Ratio
- SCSC $16.06
- SPRY N/A
- Revenue Growth
- SCSC N/A
- SPRY 8460.00
- 52 Week Low
- SCSC $31.01
- SPRY $6.00
- 52 Week High
- SCSC $53.90
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- SCSC 58.38
- SPRY 58.86
- Support Level
- SCSC $49.32
- SPRY $11.00
- Resistance Level
- SCSC $51.17
- SPRY $12.48
- Average True Range (ATR)
- SCSC 1.34
- SPRY 0.81
- MACD
- SCSC 0.34
- SPRY 0.28
- Stochastic Oscillator
- SCSC 85.27
- SPRY 84.95
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.